{"id":88793,"global_id":"www.erdheim-chester.org\/pt?id=88793","global_id_lineage":["www.erdheim-chester.org\/pt?id=88793"],"author":"20","status":"publish","date":"2025-08-26 08:06:16","date_utc":"2025-08-26 13:06:16","modified":"2025-09-10 08:58:29","modified_utc":"2025-09-10 13:58:29","url":"https:\/\/www.erdheim-chester.org\/pt\/event\/forsta-nccns-retningslinjer-for-klinisk-praksis-for-histiocytaere-svulster\/","rest_url":"https:\/\/www.erdheim-chester.org\/pt\/wp-json\/tribe\/events\/v1\/events\/88793","title":"Forst\u00e5 NCCNs retningslinjer for klinisk praksis for histiocyt\u00e6re svulster","description":"<p><a href=\"https:\/\/www.youtube.com\/watch?v=Qgg8MAMDhYc\" target=\"_blank\" rel=\"noopener\">Se webinar p\u00e5 youtube<\/a><\/p>\n<p>En gjennomgang av de nylig publiserte National Comprehensive Cancer Network (NCCN) Guidelines\u00ae for histiocytose. NCCN har utviklet disse nye retningslinjene for klinisk praksis for \u00e5 gi den nyeste evidensen og ekspertkonsensus for diagnostisering og behandling av de tre vanligste formene for histiocytose hos voksne: Langerhans cellehistiocytose (LCH), Erdheim-Chester sykdom (ECD) og Rosai-Dorfmans sykdom.<br \/>\n<em>Innspilt i juni 2021<\/em><\/p>","excerpt":"<p>En gjennomgang av de nylig publiserte National Comprehensive Cancer Network (NCCN) Guidelines\u00ae for histiocytose.<\/p>","slug":"forsta-nccns-retningslinjer-for-klinisk-praksis-for-histiocytaere-svulster","image":{"url":"https:\/\/www.erdheim-chester.org\/wp-content\/uploads\/2025\/08\/Understanding-the-NCCN-Clinical-Practice-Guidelines-for-Histiocytic-Neoplasms.png","id":93928,"extension":"png","width":1800,"height":1200,"filesize":628905,"sizes":{"medium":{"width":300,"height":200,"mime-type":"image\/png","filesize":11083,"url":"https:\/\/www.erdheim-chester.org\/wp-content\/uploads\/2025\/08\/Understanding-the-NCCN-Clinical-Practice-Guidelines-for-Histiocytic-Neoplasms-300x200.png"},"large":{"width":1024,"height":683,"mime-type":"image\/png","filesize":73624,"url":"https:\/\/www.erdheim-chester.org\/wp-content\/uploads\/2025\/08\/Understanding-the-NCCN-Clinical-Practice-Guidelines-for-Histiocytic-Neoplasms-1024x683.png"},"thumbnail":{"width":150,"height":150,"mime-type":"image\/png","filesize":5473,"url":"https:\/\/www.erdheim-chester.org\/wp-content\/uploads\/2025\/08\/Understanding-the-NCCN-Clinical-Practice-Guidelines-for-Histiocytic-Neoplasms-150x150.png"},"medium_large":{"width":768,"height":512,"mime-type":"image\/png","filesize":99448,"url":"https:\/\/www.erdheim-chester.org\/wp-content\/uploads\/2025\/08\/Understanding-the-NCCN-Clinical-Practice-Guidelines-for-Histiocytic-Neoplasms-768x512.png"},"1536x1536":{"width":1536,"height":1024,"mime-type":"image\/png","filesize":278821,"url":"https:\/\/www.erdheim-chester.org\/wp-content\/uploads\/2025\/08\/Understanding-the-NCCN-Clinical-Practice-Guidelines-for-Histiocytic-Neoplasms-1536x1024.png"},"et-pb-post-main-image":{"width":400,"height":250,"mime-type":"image\/png","filesize":34673,"url":"https:\/\/www.erdheim-chester.org\/wp-content\/uploads\/2025\/08\/Understanding-the-NCCN-Clinical-Practice-Guidelines-for-Histiocytic-Neoplasms-400x250.png"},"et-pb-post-main-image-fullwidth":{"width":1080,"height":675,"mime-type":"image\/png","filesize":163413,"url":"https:\/\/www.erdheim-chester.org\/wp-content\/uploads\/2025\/08\/Understanding-the-NCCN-Clinical-Practice-Guidelines-for-Histiocytic-Neoplasms-1080x675.png"},"et-pb-portfolio-image":{"width":400,"height":284,"mime-type":"image\/png","filesize":38329,"url":"https:\/\/www.erdheim-chester.org\/wp-content\/uploads\/2025\/08\/Understanding-the-NCCN-Clinical-Practice-Guidelines-for-Histiocytic-Neoplasms-400x284.png"},"et-pb-portfolio-module-image":{"width":510,"height":382,"mime-type":"image\/png","filesize":29014,"url":"https:\/\/www.erdheim-chester.org\/wp-content\/uploads\/2025\/08\/Understanding-the-NCCN-Clinical-Practice-Guidelines-for-Histiocytic-Neoplasms-510x382.png"},"et-pb-portfolio-image-single":{"width":1080,"height":720,"mime-type":"image\/png","filesize":78117,"url":"https:\/\/www.erdheim-chester.org\/wp-content\/uploads\/2025\/08\/Understanding-the-NCCN-Clinical-Practice-Guidelines-for-Histiocytic-Neoplasms-1080x720.png"},"et-pb-gallery-module-image-portrait":{"width":400,"height":516,"mime-type":"image\/png","filesize":28669,"url":"https:\/\/www.erdheim-chester.org\/wp-content\/uploads\/2025\/08\/Understanding-the-NCCN-Clinical-Practice-Guidelines-for-Histiocytic-Neoplasms-400x516.png"},"et-pb-image--responsive--desktop":{"width":1280,"height":853,"mime-type":"image\/png","filesize":214814,"url":"https:\/\/www.erdheim-chester.org\/wp-content\/uploads\/2025\/08\/Understanding-the-NCCN-Clinical-Practice-Guidelines-for-Histiocytic-Neoplasms-1280x853.png"},"et-pb-image--responsive--tablet":{"width":980,"height":653,"mime-type":"image\/png","filesize":67982,"url":"https:\/\/www.erdheim-chester.org\/wp-content\/uploads\/2025\/08\/Understanding-the-NCCN-Clinical-Practice-Guidelines-for-Histiocytic-Neoplasms-980x653.png"},"et-pb-image--responsive--phone":{"width":480,"height":320,"mime-type":"image\/png","filesize":22888,"url":"https:\/\/www.erdheim-chester.org\/wp-content\/uploads\/2025\/08\/Understanding-the-NCCN-Clinical-Practice-Guidelines-for-Histiocytic-Neoplasms-480x320.png"}}},"all_day":false,"start_date":"2021-06-29 13:00:00","start_date_details":{"year":"2021","month":"06","day":"29","hour":"13","minutes":"00","seconds":"00"},"end_date":"2021-06-29 14:00:00","end_date_details":{"year":"2021","month":"06","day":"29","hour":"14","minutes":"00","seconds":"00"},"utc_start_date":"2021-06-29 17:00:00","utc_start_date_details":{"year":"2021","month":"06","day":"29","hour":"17","minutes":"00","seconds":"00"},"utc_end_date":"2021-06-29 18:00:00","utc_end_date_details":{"year":"2021","month":"06","day":"29","hour":"18","minutes":"00","seconds":"00"},"timezone":"America\/New_York","timezone_abbr":"EDT","cost":"","cost_details":{"currency_symbol":"","currency_code":"","currency_position":"","values":[]},"website":"https:\/\/www.erdheim-chester.org\/pt\/event\/forsta-nccns-retningslinjer-for-klinisk-praksis-for-histiocytaere-svulster\/","show_map":true,"show_map_link":true,"hide_from_listings":false,"sticky":false,"featured":false,"categories":[{"name":"Webinarer","slug":"webinarer","term_group":0,"term_taxonomy_id":4156,"taxonomy":"tribe_events_cat","description":"","parent":0,"count":29,"filter":"raw","id":4149,"urls":{"self":"https:\/\/www.erdheim-chester.org\/pt\/wp-json\/tribe\/events\/v1\/categories\/4149","collection":"https:\/\/www.erdheim-chester.org\/pt\/wp-json\/tribe\/events\/v1\/categories"}}],"tags":[],"venue":[],"organizer":[],"custom_fields":[],"json_ld":{"@context":"http:\/\/schema.org","@type":"Event","name":"Forst\u00e5 NCCNs retningslinjer for klinisk praksis for histiocyt\u00e6re svulster","description":"&lt;p&gt;En gjennomgang av de nylig publiserte National Comprehensive Cancer Network (NCCN) Guidelines\u00ae for histiocytose.&lt;\/p&gt;\\n","image":"https:\/\/www.erdheim-chester.org\/wp-content\/uploads\/2025\/08\/Understanding-the-NCCN-Clinical-Practice-Guidelines-for-Histiocytic-Neoplasms.png","url":"https:\/\/www.erdheim-chester.org\/pt\/event\/forsta-nccns-retningslinjer-for-klinisk-praksis-for-histiocytaere-svulster\/","eventAttendanceMode":"https:\/\/schema.org\/OfflineEventAttendanceMode","eventStatus":"https:\/\/schema.org\/EventScheduled","startDate":"2021-06-29T12:00:00-05:00","endDate":"2021-06-29T13:00:00-05:00","performer":"Organization"},"is_virtual":false,"virtual_url":null,"virtual_video_source":""}